Stay updated on Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.

Latest updates to the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA funding entry for 2016 ( U.S. NIH Grant/Contract ) was added to the study page. The page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating a new site revision was deployed.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page shows a revision bump from v3.6.3 to v3.6.4, indicating a small platform update to the ClinicalTrials.gov study page rather than a change to the study details themselves.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the prior v3.6.2. This indicates a minor platform update and does not modify the study data or displayed information.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded key study documents (Study Protocol and Statistical Analysis Plans) and IPD data-sharing information. Updated record history metadata reflects recent postings and verification dates, improving transparency of the trial documentation.SummaryDifference65%

- Check92 days agoChange DetectedNew help/navigation entries were added to the study page, including 'No longer looking for participants', 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and a revised 'Intervention/Treatment' heading. The page’s revision/version label was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.